207 related articles for article (PubMed ID: 8232416)
1. Galactofuranose-containing glycoconjugates of epimastigote and trypomastigote forms of Trypanosoma cruzi.
Golgher DB; Colli W; Souto-Padrón T; Zingales B
Mol Biochem Parasitol; 1993 Aug; 60(2):249-64. PubMed ID: 8232416
[TBL] [Abstract][Full Text] [Related]
2. Structural features of LPPG and related compounds isolated from Trypanosoma cruzi trypomastigotes.
Casal OL; Zingales B; Colli W
Braz J Med Biol Res; 1994 Feb; 27(2):227-31. PubMed ID: 8081234
[TBL] [Abstract][Full Text] [Related]
3. Molecular approaches to diagnosis of Chagas' disease: use of defined antigens and a target ribosomal RNA sequence.
Zingales B; Golgher DB; Marmorato PG; Souto RP; Gruber A
Biol Res; 1993; 26(1-2):89-100. PubMed ID: 7670551
[TBL] [Abstract][Full Text] [Related]
4. Cross-reactive polysaccharides from Trypanosoma cruzi and fungi (especially Dactylium dendroides).
Schnaidman BB; Yoshida N; Gorin PA; Travassos LR
J Protozool; 1986 May; 33(2):186-91. PubMed ID: 2426444
[TBL] [Abstract][Full Text] [Related]
5. Glycoconjugates of Trypanosoma cruzi: a 74 kD antigen of trypomastigotes specifically reacts with lytic anti-alpha-galactosyl antibodies from patients with chronic Chagas disease.
Almeida IC; Krautz GM; Krettli AU; Travassos LR
J Clin Lab Anal; 1993; 7(6):307-16. PubMed ID: 8277354
[TBL] [Abstract][Full Text] [Related]
6. GPI-anchored glycoconjugates from Trypanosoma cruzi trypomastigotes are recognized by lytic anti-alpha-galactosyl antibodies isolated from patients with chronic Chagas' disease.
Almeida IC; Ferguson MA; Schenkman S; Travassos LR
Braz J Med Biol Res; 1994 Feb; 27(2):443-7. PubMed ID: 8081263
[TBL] [Abstract][Full Text] [Related]
7. Changes in isotype composition and antigen recognition of anti-Trypanosoma cruzi antibodies from acute to chronic Chagas disease.
Umezawa ES; Shikanai-Yasuda MA; Stolf AM
J Clin Lab Anal; 1996; 10(6):407-13. PubMed ID: 8951611
[TBL] [Abstract][Full Text] [Related]
8. Lytic anti-alpha-galactosyl antibodies from patients with chronic Chagas' disease recognize novel O-linked oligosaccharides on mucin-like glycosyl-phosphatidylinositol-anchored glycoproteins of Trypanosoma cruzi.
Almeida IC; Ferguson MA; Schenkman S; Travassos LR
Biochem J; 1994 Dec; 304 ( Pt 3)(Pt 3):793-802. PubMed ID: 7818483
[TBL] [Abstract][Full Text] [Related]
9. Galactofuranose-containing glycoconjugates in trypanosomatids.
de Lederkremer RM; Colli W
Glycobiology; 1995 Sep; 5(6):547-52. PubMed ID: 8563141
[TBL] [Abstract][Full Text] [Related]
10. A Trypanosoma cruzi small surface molecule provides the first immunological evidence that Chagas' disease is due to a single parasite lineage.
Di Noia JM; Buscaglia CA; De Marchi CR; Almeida IC; Frasch AC
J Exp Med; 2002 Feb; 195(4):401-13. PubMed ID: 11854354
[TBL] [Abstract][Full Text] [Related]
11. Mucin-like molecules form a negatively charged coat that protects Trypanosoma cruzi trypomastigotes from killing by human anti-alpha-galactosyl antibodies.
Pereira-Chioccola VL; Acosta-Serrano A; Correia de Almeida I; Ferguson MA; Souto-Padron T; Rodrigues MM; Travassos LR; Schenkman S
J Cell Sci; 2000 Apr; 113 ( Pt 7)():1299-307. PubMed ID: 10704380
[TBL] [Abstract][Full Text] [Related]
12. Glycosylphosphatidylinositol-anchored mucin-like glycoproteins isolated from Trypanosoma cruzi trypomastigotes initiate the synthesis of proinflammatory cytokines by macrophages.
Camargo MM; Almeida IC; Pereira ME; Ferguson MA; Travassos LR; Gazzinelli RT
J Immunol; 1997 Jun; 158(12):5890-901. PubMed ID: 9190942
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of trypomastigotes' infectivity by a monoclonal antibody directed to a glycoconjugated fraction of epimastigotes of Trypanosoma cruzi.
Imaz MS; Esteva M; Velázquez E; Ruiz AM; Segura EL; Marcipar AJ
Rev Latinoam Microbiol; 1997; 39(1-2):33-46. PubMed ID: 10932713
[TBL] [Abstract][Full Text] [Related]
14. Molecular mimicry between Trypanosoma cruzi and host nervous tissues.
Avila JL
Acta Cient Venez; 1992; 43(6):330-40. PubMed ID: 1343745
[TBL] [Abstract][Full Text] [Related]
15. Trypanosoma cruzi: characterization of two recombinant antigens with potential application in the diagnosis of Chagas' disease.
Gruber A; Zingales B
Exp Parasitol; 1993 Feb; 76(1):1-12. PubMed ID: 8467895
[TBL] [Abstract][Full Text] [Related]
16. Cell surface antigens of Trypanosoma cruzi: possible correlation with the interiorization process in mammalian cells.
Zingales B; Andrews NW; Kuwajima VY; Colli W
Mol Biochem Parasitol; 1982 Aug; 6(2):111-24. PubMed ID: 6182464
[TBL] [Abstract][Full Text] [Related]
17. Trypanosoma cruzi: recognition of trypomastigote surface antigens by lytic antisera from mice resistant to acute infection.
Yoshida N
Exp Parasitol; 1986 Apr; 61(2):184-91. PubMed ID: 3082663
[TBL] [Abstract][Full Text] [Related]
18. Trypanosoma cruzi: different surface antigens of trypomastigotes are targets of lytic antibodies.
Umezawa ES; Stolf AM; Zingales B
Acta Trop; 1993 Jun; 54(1):41-53. PubMed ID: 7690181
[TBL] [Abstract][Full Text] [Related]
19. Surface antigens of stocks and clones of Trypanosoma cruzi isolated from humans.
Zingales B; Abuin G; Romanha AJ; Chiari E; Colli W
Acta Trop; 1984 Mar; 41(1):5-16. PubMed ID: 6201059
[TBL] [Abstract][Full Text] [Related]
20. Use of Trypanosoma cruzi purified glycoprotein (GP57/51) or trypomastigote-shed antigens to assess cure for human Chagas' disease.
Gazzinelli RT; Galvao LM; Krautz G; Lima PC; Cancado JR; Scharfstein J; Krettli AU
Am J Trop Med Hyg; 1993 Nov; 49(5):625-35. PubMed ID: 8250103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
